Tumor Microenvironment-Activated Theranostics Nanozymes for Fluorescence Imaging and Enhanced Chemo-Chemodynamic Therapy of Tumors
- PMID: 34787410
- DOI: 10.1021/acsami.1c12611
Tumor Microenvironment-Activated Theranostics Nanozymes for Fluorescence Imaging and Enhanced Chemo-Chemodynamic Therapy of Tumors
Abstract
Chemodynamic therapy (CDT) is widely explored for tumor-specific therapy by converting endogenous H2O2 to lethal ·OH to destroy cancer cells. However, ·OH scavenging by glutathione (GSH) and insufficient intratumoral H2O2 levels seriously hinder the application of CDT. Herein, we reported the fabrication of copper ion-doped ZIF-8 loaded with gold nanozymes and doxorubicin hydrochloride (DOX) for the chemotherapy and CDT synergistic treatment of tumors with the assistance of tumor microenvironment (TME)-activated fluorescence imaging. The Cu2+-doped ZIF-8 shell was gradually degraded to release DOX and gold nanoclusters responding to the acidic TME. The fluorescence signal of the tumor region was acquired after the quenched fluorescence of the gold nanoclusters by Cu2+ and DOX by aggregation-induced quenching was turned on because of the interaction of GSH with Cu2+ and the release of free DOX. The Cu2+ ions could deplete the GSH via redox reactions and the generated Cu+ could convert internal H2O2 to ·OH for tumor CDT. The chemotherapeutic effect of DOX was strengthened through drug efflux inhibition and drug sensitivity increase due to the consumption of GSH and ·OH burst. Moreover, DOX could raise the level of H2O2 and augment the effect of CDT. In addition, the fluorescent gold nanoclusters not only served as a peroxidase to convert H2O2 to ·OH but also employed as an oxidase to consume GSH, resulting in the amplification of chemotherapy and CDT. This work presents an approach to construct tumor microenvironment-activated theranostic probes without external stimuli and to achieve the tumor elimination through cascade reactions and synergistic treatment.
Keywords: GSH depletion; activated fluorescence imaging; enhanced chemodynamic therapy; nanozymes; synergistic treatment.
Similar articles
-
Tumor-targeted delivery of hyaluronic acid/polydopamine-coated Fe2+-doped nano-scaled metal-organic frameworks with doxorubicin payload for glutathione depletion-amplified chemodynamic-chemo cancer therapy.J Colloid Interface Sci. 2025 Jan;677(Pt A):400-415. doi: 10.1016/j.jcis.2024.07.241. Epub 2024 Jul 31. J Colloid Interface Sci. 2025. PMID: 39096708
-
Tumor Microenvironment-Activated In Situ Synthesis of Peroxynitrite for Enhanced Chemodynamic Therapy.ACS Nano. 2024 Oct 1;18(39):27042-27054. doi: 10.1021/acsnano.4c10012. Epub 2024 Sep 19. ACS Nano. 2024. PMID: 39298299
-
ATP-responsive copper(II)-doped ZIF-nanoparticles for synergistic cancer therapy: combining cuproptosis and chemo/chemodynamic therapy.J Mater Chem B. 2024 Nov 13;12(44):11414-11425. doi: 10.1039/d4tb01574f. J Mater Chem B. 2024. PMID: 39380332
-
The Application of Biomedicine in Chemodynamic Therapy: From Material Design to Improved Strategies.Bioengineering (Basel). 2023 Aug 3;10(8):925. doi: 10.3390/bioengineering10080925. Bioengineering (Basel). 2023. PMID: 37627810 Free PMC article. Review.
-
Strategies to engineer various nanocarrier-based hybrid catalysts for enhanced chemodynamic cancer therapy.Chem Soc Rev. 2023 Nov 13;52(22):7707-7736. doi: 10.1039/d3cs00356f. Chem Soc Rev. 2023. PMID: 37874584 Review.
Cited by
-
Metal-Organic Frameworks-Mediated Assembly of Gold Nanoclusters for Sensing Applications.J Anal Test. 2022;6(2):163-177. doi: 10.1007/s41664-022-00224-0. Epub 2022 May 7. J Anal Test. 2022. PMID: 35572781 Free PMC article. Review.
-
Nanotechnology-Assisted Immunogenic Cell Death for Effective Cancer Immunotherapy.Vaccines (Basel). 2023 Aug 31;11(9):1440. doi: 10.3390/vaccines11091440. Vaccines (Basel). 2023. PMID: 37766117 Free PMC article. Review.
-
NIR-triggered and glucose-powered hollow mesoporous Mo-based single-atom nanozymes for cascade chemodynamic diabetic infection therapy.Mater Today Bio. 2025 Feb 5;31:101557. doi: 10.1016/j.mtbio.2025.101557. eCollection 2025 Apr. Mater Today Bio. 2025. PMID: 40026620 Free PMC article.
-
Removing Barriers to Tumor 'Oxygenation': Depleting Glutathione Nanozymes in Cancer Therapy.Int J Nanomedicine. 2025 May 1;20:5613-5643. doi: 10.2147/IJN.S515734. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40331231 Free PMC article. Review.
-
Recent theranostic applications of hydrogen peroxide-responsive nanomaterials for multiple diseases.RSC Adv. 2023 Sep 12;13(39):27333-27358. doi: 10.1039/d3ra05020c. eCollection 2023 Sep 8. RSC Adv. 2023. PMID: 37705984 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources